Immunofluorescence (IF) results showed that, compared with the control group, the positive expression levels of TWEAK and its transmembrane receptor FN14 were significantly decreased in tumor tissue following Butein treatment (Figures 4A–C). This evidence concerns the gene NRP1 and neoplasm.